Q32 Bio (QTTB) Enterprise Value (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.08% |
| Dec 31, 2025 | 29.95% |
| Sep 30, 2025 | -25.74% |
| Jun 30, 2025 | 16.27% |
| Mar 31, 2025 | 16.01% |
| Dec 31, 2024 | 12.48% |
| Sep 30, 2024 | 17.25% |
| Jun 30, 2024 | 20.45% |
| Mar 31, 2024 | -428.21% |
| Dec 31, 2023 | 76.81% |
| Sep 30, 2023 | -57.04% |
| Jun 30, 2023 | 50.46% |
| Mar 31, 2023 | 18.88% |
| Dec 31, 2022 | 12.95% |
| Sep 30, 2022 | 10.84% |
| Jun 30, 2022 | 11.95% |
| Mar 31, 2022 | -62.28% |
| Dec 31, 2021 | 15.85% |
| Sep 30, 2021 | 12.59% |
| Jun 30, 2021 | -12.98% |
| Mar 31, 2021 | 13.16% |
| Dec 31, 2020 | -21.99% |
| Sep 30, 2020 | 13.24% |
| Jun 30, 2020 | 12.51% |
| Mar 31, 2020 | 10.41% |
| Dec 31, 2019 | 2.23% |
| Sep 30, 2019 | 9.22% |
| Jun 30, 2019 | -56.98% |
| Mar 31, 2019 | 12.59% |
| Dec 31, 2018 | 9.54% |
| Sep 30, 2018 | 6.33% |
| Jun 30, 2018 | -115.61% |
| Mar 31, 2018 | 9.84% |
| Dec 31, 2017 | -34.43% |
| Sep 30, 2017 | -378.56% |
| Jun 30, 2017 | 22.90% |